Lung cancer is the most common forms of cancer and the leading cause of deaths. A recent study has been published in the European Journal of Pharmaceutical Sciences. According to this study,…
Tag: Treating Lung Cancer
Study: Physical Tests Vital in Treating Metastatic Lung Cancer
According to a new study from the researchers in Brazil and the United States, simple physical tests like sitting down, standing up and walking can significantly aid physicians in managing treatments for…
Understanding TIL Therapy for Lung Cancer
Lung cancer is the leading cause of cancer related deaths all around the world. Although there are various advanced treatment options and several approaches, the survival rate remains low. Here, in this…
Roche’s Genentech Gets FDA Approval for Lung Cancer Treatment
Genetech, a member of the Roche Group, had announced that U.S. Food and Drug Administration (FDA) has approved Alecensa (alectinib) for adjuvant treatment of patients with early stage, anaplastiv lymphoma kinase-positive non-small…
Lung Cancer Cell “Memories” Suggest New Strategy for Improving Treatment
A new understanding of lung cancer cells “memories” suggest a new strategy for improving lung cancer treatment, according to Memorial Sloan Kettering Cancer Center (MSK) researchers. In this research, they have found…
Trial Shows Novel Vaccine’s Potential for Lung Cancer Treatment
A new vaccine has shown to improve survival rate among people suffering from lung cancer. A French biotechnology company said that Ose Immunotherapeutics’ Tedopi vaccine was effective in decreasing death risk among lung…
Tumor Treating Fields to Improve Survival Benefit in Lung Cancer
Tumor Treating Fields (TTFields) are electric fields that disrupt processes which are critical for the survival of cancer cells. This leads to immunogenic cell death and enhanced antitumor immune response. The use…
Quratusugene Ozeplasmid for Small Cell Lung Cancer Receives Orphan Drug Designation by FDA
Genprex, Inc. is a clinical-stage gene therapy company and has announced the United States Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to the drug, Reqorsa Immunogene Therapy (quratusugene…